Skip to content

Drug interactions

Ropinirole + Talquetamab

Severity: Minor

Ropinirole and Talquetamab: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Talquetamab causes cytokine release syndrome that can transiently suppress CYP enzymes. Ropinirole exposure may rise during step-up dosing and shortly afterward, increasing dopaminergic adverse effects.

What this interaction means in plain words

Ropinirole and Talquetamab have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Ropinirole belongs to Central Nervous System; Talquetamab belongs to Oncology.

Evidence level: Low

Why it happens

Cytokine-mediated suppression of CYP1A2 and other CYP enzymes reduces ropinirole clearance.

What to do

Monitor for somnolence, dizziness, nausea and hypotension during step-up dosing and for about two weeks after. Reduce the ropinirole dose if adverse effects appear.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ropinirole and Talquetamab, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Ropinirole with Talquetamab?

MediHelp rates the interaction as minor. Ropinirole and Talquetamab have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Talquetamab causes cytokine release syndrome that can transiently suppress CYP enzymes. Ropinirole exposure may rise during step-up dosing and shortly afterward, increasing dopaminergic adverse effects.

How serious is the interaction between Ropinirole and Talquetamab?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for somnolence, dizziness, nausea and hypotension during step-up dosing and for about two weeks after. Reduce the ropinirole dose if adverse effects appear.

What other medicines interact with Ropinirole?

MediHelp also lists interactions of Ropinirole with, for example, Amisulpride, Chlorpromazine, Droperidol. The full list is on the Ropinirole page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in